Cipher Pharmaceuticals Inc. (CPHRF)
OTCMKTS · Delayed Price · Currency is USD
10.60
-0.03 (-0.29%)
Dec 4, 2025, 10:48 AM EST
Cipher Pharmaceuticals Market Cap
Cipher Pharmaceuticals has a market cap or net worth of $269.27 million as of December 4, 2025. Its market cap has increased by 0.37% in one year.
Market Cap
269.27M
Enterprise Value
274.24M
Revenue
50.06M
Ranking
n/a
PE Ratio
15.51
Stock Price
$10.60
Market Cap Chart
Since February 25, 2004, Cipher Pharmaceuticals's market cap has increased from 58.00M to 269.27M, an increase of 364.30%. That is a compound annual growth rate of 7.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 269.27M | 5.73% |
| Dec 31, 2024 | 254.68M | 152.73% |
| Dec 29, 2023 | 100.77M | 41.37% |
| Dec 30, 2022 | 71.28M | 94.22% |
| Dec 31, 2021 | 36.70M | 86.01% |
| Dec 31, 2020 | 19.73M | -36.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Elite Pharmaceuticals | 571.69M |
| Glass House Brands | 486.41M |
| American Oncology Network | 429.20M |
| CytoDyn | 414.34M |
| Northwest Biotherapeutics | 394.75M |
| Silence Therapeutics | 318.36M |
| Nika Pharmaceuticals | 259.91M |